Hepatitis B surface antigen (HBsAg) prevalence in Mauritania
Mauritania: Hepatitis B surface antigen (HBsAg) prevalence was 1.4% in 2024. ▼ Falling
Latest (2024)
1.4%
Change on year
unchanged
World rank
19th
of 194 countries
All-time high
3.4%
in 2015
All-time low
1.4%
in 2023
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Mauritania, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Mauritania is 1.4%, measured in 2024. That is the lowest value across all 10 years on record.
The figure is down 58.8% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Mauritania peaked at 3.4% in 2015 and was at its lowest, 1.4%, in 2023.
That places Mauritania 19th out of 194 countries with data for 2024, putting it in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Mauritania, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 3.4% | — |
| 2016 | 3.0% | -11.8% |
| 2017 | 2.7% | -10.0% |
| 2018 | 2.5% | -7.4% |
| 2019 | 2.3% | -8.0% |
| 2020 | 2.0% | -13.0% |
| 2021 | 1.6% | -20.0% |
| 2022 | 1.5% | -6.3% |
| 2023 | 1.4% | -6.7% |
| 2024 | 1.4% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.8% | 2.3% | 3.4% | 5 |
| 2020s | 1.6% | 1.4% | 2.0% | 5 |
Countries ranked near Mauritania
- 17 South Sudan 1.7% compare
- 18 Congo 1.6% compare
- 19 Solomon Islands 1.4% compare
- 19 Togo 1.4% compare
- 19 Congo, Democratic Republic of the 1.4% compare
- 19 Lesotho 1.4% compare
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Heat deaths vs projected death rates 653 (2090)
- Un projection of annual infant deaths 1,563 (2100)
- Population ages 65 and above, female, annual growth rate 3.88 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0177 units per person (2025)
- Population ages 65 and above, male, annual growth rate 2.83 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0147 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Mauritania?
- Hepatitis b surface antigen (hbsag) prevalence in Mauritania was 1.4% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Mauritania?
- The highest recorded value was 3.4% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Mauritania?
- The lowest recorded value was 1.4% in 2023.
- How does Mauritania rank for hepatitis b surface antigen (hbsag) prevalence?
- Mauritania ranks 19th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Mauritania?
- Over the last ten years it is down 58.8%. The long-run trend across the full record is falling.
- Where does this Mauritania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).